期刊文献+

KLK4在子宫内膜癌组织中的表达及临床意义 被引量:3

下载PDF
导出
摘要 采用RT-PCR和免疫组织化学方法检测68例子宫内膜腺癌组织、13例增生性子宫内膜和15例正常子宫内膜组织中激肽释放酶基因4(KLK4)的表达情况。发现KLK4 mRNA和蛋白在子宫内膜癌组织中过表达,明显高于正常子宫内膜及增生内膜(P均<0.01)。KLK4蛋白主要表达于子宫内膜组织腺上皮细胞核内,各组中的内膜组织均有不同程度的表达。KLK4与手术病理分期无关,但与组织分化程度相关(P<0.05)。认为KLK4可能与子宫内膜腺上皮细胞的增殖和分化有关,在子宫内膜癌的发生和发展中具有一定的作用。
出处 《山东医药》 CAS 北大核心 2009年第4期96-97,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family [ J ]. Cancer Lett, 2007,249 ( 1 ) : 61 - 79.
  • 2Klokk TI, Kilander A, Xi Z, et al. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer [ J ]. Cancer Res, 2007,67( 11 ) :5221-5230.
  • 3Lawrence MG, Veveris-Lowe TL, Whitbread AK, et al. Epithelial- mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases [ J]. Cells Tissues Organs, 2007,185 ( 1 - 3) :111-115.
  • 4Gao J, Collard RL, Bui L, et al. Kallikrein d is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer [J]. Prostate, 2007,67(4) :348-360.
  • 5Xi Z, Kaem J, Davidson B, Klokk TI, et al. Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer [ J ]. Gyneeol Oncol, 2004,94( 1 ) :80-85.
  • 6Dong Y, Kaushal A, Bui L, et al. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas [ J ]. Clin Cancer Res, 2001,7(8) :2363-2371.

同被引文献47

  • 1吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 2黄玮,钟捷.NES1基因与肿瘤研究[J].国外医学(肿瘤学分册),2005,32(5):345-347. 被引量:1
  • 3黄金凤,李炜霞,何志明,章锦芳.子宫内膜癌MDM_2和CD44v6联合检测的临床意义[J].黑龙江医学,2007,31(4):243-244. 被引量:6
  • 4李巧云,史惠蓉,颜秋梅.人激肽释放酶蛋白14在宫颈癌中的表达[J].第三军医大学学报,2007,29(14):1449-1450. 被引量:1
  • 5Dong Y, Kaushal A, Bui L,et al. Human kallikreins( k1k4 )is highly expressed in serous ovarian carcinomas[J]. Clin Cancer Res,2001, 7(8) :2363 -71.
  • 6Myers SA,Clements JA. Kallikrein 4(KLK4) ,a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometfial cancer cell line, KLE [J]. J Clin Endocfinol Metab,2001,86(5 ) :2323 - 6.
  • 7Morgan RJ, Newcomb PV, Hardwick RH, et al. Amplification of cyclin D1 and MDM -2 in oesophageal carcinoma[ J]. Eur J Surg Oncol, 1999,25 (4) : 364 - 7.
  • 8Jeczen R, Skomra D, Cybulski M, et al. P53/MDM2 overexpression in metastatic endometrial cancer:correlation with elinicopathological features and patient outcome [J]. Clin Exp Metastasis, 2007,24 (7) :503 - 11.
  • 9Tang X, Milyavsky M, Shats I,et al. Activated p53 suppresses the histone methyltransferase EZH2 gene [ J ]. Oncogene, 2004, 23 (34) :5759 - 69.
  • 10Kato N,Tamura G, Fukase M, et al. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants [ J ]. Am J Pathol,2003,163 ( 2 ) :387 - 91.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部